Process for synthesis of prulifloxacin and its pharmaceutical composition
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 哈尔滨健迪医药技术有限公司
- Publication Date
- 2005-12-07
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to prulifloxacin ((±)-6-fluoro-1-methyl-7-[4-(5-methyl-2-oxo-1,3-dioxol-4 base) Methyl-1-piperazine]-4-oxo-4hydro-[1,3]thiazetidino[3,2-α]quinoline-3-carboxylic acid) (I) new synthetic antibacterial drug synthesis process.
[0002]
[0003] (I) technical background
[0004] Synthetic antibacterial agents widely used in the treatment of infections caused by Gram-negative bacteria include enoxacin, ofloxacin, and ciprofloxacin. However, these antibacterial preparations cannot meet the growing and refractory diseases in recent years, namely the treatment of chronic Pseudomonas aeruginosa infection and Gram-negative bacterial infection. It has good absorption, excellent pharmacokinetic properties, broad antibacterial spectrum and strong antibacterial effect, and is a clinically effective antibacterial preparation.
[0005] The antibacterial preparation was the first to be a new generation of a...